癌症治疗中的G-四重复合联体:进展,挑战和临床前景
Joana Figueiredo1, Jean-Louis Mergny2, Carla Cruz3
1CICS-UBI - Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal.
Life sciences
|February 1, 2024
概括
关氨酸四复合体 (G4) 是有希望的抗癌标. 本综述详细介绍了G4连接体的发展,结构-活性关系以及新型癌症治疗的临床进展.
科学领域:
- 生物化学和分子生物学
- 药用化学 医学化学
- 在瘤学瘤学.
背景情况:
- 富含关氨酸的DNA序列在细胞中形成G-四重复 (G4) 结构.
- G4结构被认为是潜在的抗癌治疗点.
- 尽管进行了广泛的研究,但目前还没有任何针对G4的药物被批准用于临床使用.
研究的目的:
- 为了审查G-四重复 (G4) 连接体的结构-活性关系.
- 讨论G4向化合物的体内效应和临床试验状态.
- 为开发强效和选择性G4向分子用于癌症治疗提供见解.
主要方法:
- 关于G-四重复 (G4) 配体的文献综述.
- 对G4结合剂的结构-活性关系 (SAR) 的分析.
- 对G4向剂的体内数据和临床试验结果的评估.
主要成果:
- G4联体表现出多样化的结构和结合方式.
- 结构-活性关系对于优化G4连接体强度和选择性至关重要.
- 几种G4配体在体外和体内表现出有前途的抗癌活性,其中一些进展到临床试验.
结论:
- 在抗癌药物开发中,G-四重复体是一种可行的标类.
- 了解SAR是设计有效和选择性的G4配体的关键.
- 对G4向剂的进一步临床研究具有治疗癌症治疗的治疗潜力.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


